|
Katie doing ‘extremely well’ following stem cell transplant
Waterloo Record file photo. next play/pause pre. Cambridge Times. By Lisa Rutledge. TORONTO – Cambridge’s Katie Herron remains in isolation at Toronto Sick Kids hospital in an effort to rebuild her immune system following last week’s six-hour stem cell transplant. |
Katie doing 'extremely well' following stem cell transplant – Cambridge Times
|
Katie doing ‘extremely well’ following stem cell transplant
Cambridge Times TORONTO – Cambridge’s Katie Herron remains in isolation at Toronto Sick Kids hospital in an effort to rebuild her immune system following last week’s six-hour transplant stem cell transplant. It’s a critical time for the little girl, as her immune … |
HOLD WEEKEND LEAD – Heart failure care in region is 'among the best in UK' – The Northern Echo
The Northern Echo |
HOLD WEEKEND LEAD – Heart failure care in region is ‘among the best in UK’
The Northern Echo Professor Ahmet Fuat – a Darlington GP who is an honorary primary care cardiology professor at Durham University – caused a stir when he recently published research showing that the care of heart failure patients in the UK is inadequate and has not … |
Tissue Diagnostics Market Worth $3924.01 Million by 2018 – PR Newswire (press release)
|
Tissue Diagnostics Market Worth $3924.01 Million by 2018
PR Newswire (press release) The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others … |
Depression May Raise Heart Failure Risk – Huffington Post
Depression May Raise Heart Failure RiskHuffington PostAn association was found between depression and heart failure; people with mild depression had a slightly increased risk of heart failure over that time period — just 5 percent. However, people wit…
FDA Grants “Breakthrough Therapy” Status for Gene Therapy to reduce Systolic … – Next Big Future
|
FDA Grants “Breakthrough Therapy” Status for Gene Therapy to reduce Systolic …
Next Big Future Tweet Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies, announced that its lead product candidate, … FDA grants breakthrough therapy status for Celladon’ heart failure treatment …Pharmaceutical Business Review |
Headteacher Vina Pankhania takes MONTH off during term time to get married – Daily Mail
Daily Mail |
Headteacher Vina Pankhania takes MONTH off during term time to get married
Daily Mail Governors have allowed her to take her extra term time holiday as ‘unpaid leave’ so she can marry fiancé Amit Jain in India in May. While she is away the acting deputy head Helen Cartledge-Splitt will be in charge of the school, which has about 360 … |
Parkridge Medical Center Earns Quality Achievement Award For Heart Failure … – The Chattanoogan
The Chattanoogan |
Parkridge Medical Center Earns Quality Achievement Award For Heart Failure …
The Chattanoogan Parkridge Medical Center has received the Get With The Guidelines–Heart Failure Gold-Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American College of Cardiology … |
Woman vows to finish bucket list of young organ donor who saved her life – Yahoo Canada Shine On (blog)
Yahoo Canada Shine On (blog) |
Woman vows to finish bucket list of young organ donor who saved her life
Yahoo Canada Shine On (blog) Kristina Chesterman was a 21-year-old at Chico State when she was killed by an alleged drunk driver. (ABC News … A 64-year-old California woman whose life was saved by a young organ donor has vowed to fulfill the bucket list of the woman who gave her … Heart recipient promises to check off items on donor’s bucket listNew York Daily News Family, friends to fulfill bucket list for nursing student killed by drunk driverToday.com Woman Vows to Live Out Heart Donor’s Bucket ListNewser |
National Cancer Institute investigating trial outliers to resurrect 'failed' drugs – FierceBiotech
|
National Cancer Institute investigating trial outliers to resurrect ‘failed’ drugs
FierceBiotech The patient, who had advanced bladder cancer, experienced a complete response for 14 months to the drug combination everolimus (Afinitor) and pazopanib (Votrient) in a Phase I trial. In the trial, investigators recruited 9 patients with advanced solid … |